Brief: Spago Nanomedical To Be Granted US Patent For Tumorad
March 5 (Reuters) - Spago Nanomedical Ab (Publ) SPAGO.TE :
* SPAGO NANOMEDICAL TO BE GRANTED US PATENT FOR TUMORAD®
* PATENT WILL SECURE MARKET EXCLUSIVITY IN USA UNTIL AT
LEAST
2035
Source text for Eikon: ID:nWkrbRCmqT
Further company coverage: SPAGO.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))